The Child Cancer Foundation have released their flyer for the 2025 Health Professionals Grant. The purpose of the Grant is to support Health Professionals such as Doctors, Nurses, Social Workers and other Allied Health professionals who spend the majority of their role delivering Paediatric Oncology...
The National Child Cancer Network (NCCN) welcomes the Government's recent announcement of significant changes to the National Travel Assistance (NTA) programme. The announcement, effective April 1st, 2024, included a much-needed 50% funding increase ($18 million), raising mileage rates from 28 cents to 34 cents per kilometre...
The National Child Cancer Network applauds the decision to retain Pharmac rule 8.1b which allows for children with cancer to continue to access modern cancer pharmaceuticals. This rule has played a critical role in establishing a world-class, equitable treatment pathway for childhood cancer in New Zealand,...
NCCN is delighted to celebrate the recent knighthood of Dr. Scott Macfarlane for services to health. This prestigious recognition in the 2024 New Year Honours list is a well-deserved tribute to Dr. Macfarlane's dedication throughout his career to transforming the treatment and improving outcomes for...
We are seeking expressions of interest from interested and suitably qualified people to become members of the Governance Group for the Network. The Governance Group is a new group that is being established. The Group will determine and oversee the NCCN strategic direction, strategic priorities, and...
Updated analysis on childhood cancer incidence and survival for the periods 2015–2019 and 2010-2019 have now been produced by the National Child Cancer Network. We are pleased to report that the overall childhood cancer survival in Aotearoa, New Zealand has continued to rise and remains on...
After more than 35 years as a peadiatrician and paediatric oncologist Scott Macfarlane officially retired on 5 November 2021 as National Clinical Leader: Child Cancer, a post he has held for the last decade. Due to Covid-19 restrictions NCCN members were not able to meet...
We are excited to announce that NCCN’s new Clinical Lead is Dr Stephen Laughton, Paediatric Oncologist and Neuro-Oncologist, based at Starship Blood and Cancer Centre. Dr Laughton has been involved in paediatric oncology for over 20 years and his specific area of interest and expertise...
A Private Member’s Bill from Dr Shane Reti, National Party Health spokesperson and Deputy Leader of the National Party, seeks to achieve public hospital access for patients paying for unfunded chemotherapy (which they have purchased), and is currently given in private clinics at their expense. A...
ANZCHOG has recently released updated guidance recommending all children (aged 12 years and over) and adolescents, including those with cancer and receiving cancer treatment or who recently completed cancer treatment should be vaccinated against COVID-19. The location where the child should receive the vaccination should...